tradingkey.logo

Catheter Precision Inc

VTAK
1.890USD
+0.050+2.81%
Handelsschluss 02/06, 16:00ETKurse um 15 Minuten verzögert
3.11MMarktkapitalisierung
0.05KGV TTM

Catheter Precision Inc

1.890
+0.050+2.81%

mehr Informationen über Catheter Precision Inc Unternehmen

Catheter Precision, Inc. is a medical device company bringing solutions to market to improve the treatment of cardiac arrhythmias. The Company is focused on developing technology for electrophysiology (EP) procedures by collaborating with physicians and continuously advancing its products. The Company's two primary products are the View into Ventricular Onset System (VIVO System) and LockeT. The VIVO System is a non-invasive imaging system that offers three-dimensional (3D) cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. Its product, LockeT, is a suture retention device indicated for wound healing by distributing suture tension over a larger area in the patient in conjunction with a figure of eight suture closure. Its product portfolio also includes the Amigo Remote Catheter System. It is developing technology for the treatment of acute decompensated heart failure.

Catheter Precision Inc Informationen

BörsenkürzelVTAK
Name des UnternehmensCatheter Precision Inc
IPO-datumSep 27, 2018
CEOJenkins (David A)
Anzahl der mitarbeiter22
WertpapierartOrdinary Share
GeschäftsjahresendeSep 27
Addresse1670 Highway 160 West
StadtFORT MILL
BörseNASDAQ OMX – NASDAQ Basic Amex
LandUnited States of America
Postleitzahl29708
Telefon19736912000
Websitehttps://www.ramed.com/
BörsenkürzelVTAK
IPO-datumSep 27, 2018
CEOJenkins (David A)

Führungskräfte von Catheter Precision Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. David Jenkins
Mr. David Jenkins
Executive Chairman of the Board, Chief Executive Officer, Chief Commercial Officer
Executive Chairman of the Board, Chief Executive Officer, Chief Commercial Officer
22.28K
+12064.00%
Mr. Martin J. Colombatto
Mr. Martin J. Colombatto
Independent Director
Independent Director
2.00
--
Mr. James J. Caruso
Mr. James J. Caruso
Independent Director
Independent Director
--
--
Mr. Tony Dacosta
Mr. Tony Dacosta
Investor Relations
Investor Relations
--
--
Mr. Philip J. Anderson
Mr. Philip J. Anderson
Chief Financial Officer, Secretary
Chief Financial Officer, Secretary
--
--
Mr. Andrew (Andy) Arno
Mr. Andrew (Andy) Arno
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. David Jenkins
Mr. David Jenkins
Executive Chairman of the Board, Chief Executive Officer, Chief Commercial Officer
Executive Chairman of the Board, Chief Executive Officer, Chief Commercial Officer
22.28K
+12064.00%
Mr. Martin J. Colombatto
Mr. Martin J. Colombatto
Independent Director
Independent Director
2.00
--
Mr. James J. Caruso
Mr. James J. Caruso
Independent Director
Independent Director
--
--
Mr. Tony Dacosta
Mr. Tony Dacosta
Investor Relations
Investor Relations
--
--
Mr. Philip J. Anderson
Mr. Philip J. Anderson
Chief Financial Officer, Secretary
Chief Financial Officer, Secretary
--
--
Mr. Andrew (Andy) Arno
Mr. Andrew (Andy) Arno
Independent Director
Independent Director
--
--

Umsatzaufteilung

Währung: USDAktualisiert: Tue, Jan 6
Währung: USDAktualisiert: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q2
FY2023Q1
FY2022
FY2021
FY2020
FY2019
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Nach RegionUSD
Name
Umsatz
Anteil
United States
172.00K
76.11%
All other countries
54.00K
23.89%
Nach Geschäftsbereich
Nach Region
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.

Aktionärsstatistik

Aktualisiert: Sat, Jan 31
Aktualisiert: Sat, Jan 31
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Jenkins (David A)
1.34%
The Vanguard Group, Inc.
0.94%
FatBoy Capital LP
0.22%
Caruso (James Joseph)
0.11%
UBS Financial Services, Inc.
0.09%
Andere
97.30%
Aktionäre
Aktionäre
Anteil
Jenkins (David A)
1.34%
The Vanguard Group, Inc.
0.94%
FatBoy Capital LP
0.22%
Caruso (James Joseph)
0.11%
UBS Financial Services, Inc.
0.09%
Andere
97.30%
Aktionärstypen
Aktionäre
Anteil
Individual Investor
1.45%
Investment Advisor
1.06%
Corporation
0.22%
Andere
97.26%

Institutionelle Beteiligung

Aktualisiert: Thu, Jan 1
Aktualisiert: Thu, Jan 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q4
25
17.75K
1.06%
-33.21K
2025Q3
23
24.65K
1.66%
-10.09K
2025Q2
30
1.62M
12.88%
+225.25K
2025Q1
34
1.39M
13.16%
+226.78K
2024Q4
37
1.12M
13.97%
-215.80K
2024Q3
45
563.38K
38.63%
+376.14K
2024Q2
46
202.02K
23.51%
+5.34K
2024Q1
50
211.28K
24.77%
+47.42K
2023Q4
52
169.47K
25.10%
+5.69K
2023Q3
56
180.73K
31.24%
+30.19K
Mehr Anzeigen

Aktionärsaktivitäten

Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Jenkins (David A)
22.28K
1.34%
+12.06K
+118.07%
Dec 05, 2025
FatBoy Capital LP
3.73K
0.22%
--
--
Jan 29, 2025
Caruso (James Joseph)
1.88K
0.11%
+41.00
+2.23%
Dec 05, 2025
Manulife Investment Management (North America) Limited
531.00
0.03%
--
--
Oct 31, 2025
Jenkins Linda A
12.00
0%
--
--
Jan 29, 2025
BofA Global Research (US)
10.00
0%
+4.00
+66.67%
Sep 30, 2025
Harbour Investments, Inc
8.00
0%
--
--
Sep 30, 2025
SBI Securities Co., Ltd.
5.00
0%
-53.00
-91.38%
Sep 30, 2025
Mehr Anzeigen

Verbundene ETFs

Name
Anteil
Keine Daten

Dividende

In den vergangenen 5 Jahren wurden insgesamt 0.00 USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten

Aktien-Split

Datum
Ex-Dividendentag
Art
Verhältnis
Jul 28, 2025
Merger
19→1
Jul 03, 2024
Merger
10→1
Jul 03, 2024
Merger
10→1
Jul 03, 2024
Merger
10→1
Jul 03, 2024
Merger
10→1
Sep 21, 2022
Merger
50→1
Datum
Ex-Dividendentag
Art
Verhältnis
Jul 28, 2025
Merger
19→1
Jul 03, 2024
Merger
10→1
Jul 03, 2024
Merger
10→1
Jul 03, 2024
Merger
10→1
Jul 03, 2024
Merger
10→1
Sep 21, 2022
Merger
50→1
Sep 21, 2022
Merger
50→1
Sep 21, 2022
Merger
50→1
Sep 21, 2022
Merger
50→1
Nov 16, 2020
Merger
25→1
Mehr Anzeigen
KeyAI